Oral Cellular Immunotherapy
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
100
NCT02370043
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect of KQ-791
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 28, 2015
Completion: Jul 31, 2015
NCT02445911
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of KQ-791 in Diabetes Mellitus
Start: Jun 30, 2015
Completion: Feb 29, 2016
Loading map...